In conclusion, SCD4 downregulation reduced obesity and had beneficial effects on the heart under HFD conditions, preventing cardiac steatosis, reducing ROS levels, preventing mitochondrial enlargement, and maintaining cardiac function and structure. The gene discussed is SCD5; the disease is obesity due to melanocortin 4 receptor deficiency.